Advanced proteomic technologies for cancer biomarker discovery

References

• Duffy MJ, van Dalen A, Haglund C et al. Tumor markers in colorectal caner: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur. J. Cancer43(9), 1348–1360 (2007).
   PubMed Web of Science ®Google Scholar
• Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur. J. Intern. Med.18(3), 175–184 (2007).
   PubMed Web of Science ®Google Scholar
• Bertucci F, Birnbaum D, Goncalves A. Proteomics of breast cancer: principles and potential clinical applications. Mol. Cell. Proteomics5(10), 1772–1786 (2006).
   PubMed Web of Science ®Google Scholar
• Feng JT, Shang S, Beretta L. Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene25(27), 3810–3817 (2006).
   Google Scholar
• Miller I, Crawford J, Gianazza E. Protein stains for proteomic applications: which, when, why? Proteomics6(20), 5385–5408 (2006).
   PubMed Web of Science ®Google Scholar
• Kumarathasan P, Mohottalage S, Goegan P, Vincent R. An optimized protein in-gel digest method for reliable proteome characterization by MALDI-TOF-MS analysis. Anal. Biochem.346(1), 85–89 (2005).
   PubMed Web of Science ®Google Scholar
• Meunier B, Bouley J, Piec I, Bernard C, Picard B, Hocquette JF. Data analysis methods for detection of differential protein expression in two-dimensional gel electrophoresis. Anal. Biochem.340(2), 226–230 (2005).
   Google Scholar
• Chan CM, Wong SC, Lam MY et al. Proteomic comparison of nasopharyngeal cancer cell lines C666–1 and NP69 identifies down-regulation of annexin II and β2-tubulin for nasopharyngeal carcinoma. Arch. Pathol. Lab. Med.132(4), 675–683 (2008).
   PubMed Web of Science ®Google Scholar
• Wong SC, Wong VW, Chan CM et al. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol. Rep.20(1), 89–98 (2008).
   Google Scholar
• Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. BioAnal. Chem.382(3), 669–678 (2005).
   PubMed Web of Science ®Google Scholar
• Timms JF, Cramer R. Difference gel electrophoresis. Proteomics8(23–24), 4886–4897 (2008).
   PubMed Web of Science ®Google Scholar
• Minden J. Comparative proteomics and difference gel electrophoresis. Biotechniques43(6), 739–745 (2007).
   PubMed Web of Science ®Google Scholar
• Kondo T, Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc.1(6), 2940–2986 (2007).
   Web of Science ®Google Scholar
• Kang Y, Techanukul T, Mantalaris A, Nagy JM. Comparison of three commercially available DIGE analysis software packages: minimal user intervention in gel-based proteomics. J. Proteome Res.8(2), 1077–1084 (2009).
   Google Scholar
• Kreil DP, Karp NA, Lilley KS. DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results. Bioinformatics20(13), 2026–2034 (2004).
   PubMed Web of Science ®Google Scholar
• Karp NA, McCormick PS, Russell MR, Lilley KS. Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis. Mol. Cell. Proteomics6(8), 1354–1364 (2007).
   PubMedGoogle Scholar
• Kleno TG, Leonardsen LR, Kjeldal HØ, Laursen SM, Jensen ON, Baunsgaard D. Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics4(3), 868–880 (2004).
   PubMed Web of Science ®Google Scholar
• Smit S, Hoefsloot HCJ, Smilde AK. Statistical data processing in clinical proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.866(1–2), 77–88 (2008).
   Google Scholar
• Karp NA, Griffin JL, Lilley KS. Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics. Proteomics5(1), 81–90 (2005).
   PubMed Web of Science ®Google Scholar
• Grove H, Jørgensen BM, Jessen F et al. Combination of statistical approaches for analysis of 2-DE data gives complementary results. J. Proteome Res.7(12), 5119–5124 (2008).
   PubMed Web of Science ®Google Scholar
• Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic serum using differential gel electrophoresis and tandem mass spectrometry. J. Proteome Res.4(5), 1742–1751 (2005).
   PubMed Web of Science ®Google Scholar
• Huang H-L, Stasyk T, Morandell S et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis27(8), 1641–1650 (2006).
   PubMed Web of Science ®Google Scholar
• Sun W, Xing B, Sun Y et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol. Cell. Proteomics6(10), 1798–1808 (2007).
   PubMed Web of Science ®Google Scholar
• Wong SC, Chan AT, Chan JK, Lo YM. Nuclear β-catenin and Ki-67 expression in chriocarcinoma and its pre-malignant form. J. Clin. Pathol.59(4), 387–392 (2006).
   PubMed Web of Science ®Google Scholar
• Chan CM, Ma BB, Hui EP et al. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma: a prognostic evaluation and correlation with hypoxia inducible factor 1 α and vascular endothelial growth factor. Oral Oncol.43(4), 373–378 (2007).
   PubMed Web of Science ®Google Scholar
• Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High throughput proteomic analysis of formalin-fixed paraffin embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics8(18), 3715–3724 (2008).
   PubMed Web of Science ®Google Scholar
• Lemaire R, Desmons A, Tabet JC, Day R, Salzet M, Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J. Proteome Res.6(4), 1295–1305 (2007).
   PubMed Web of Science ®Google Scholar
• Meistermann H, Norris JL, Aerni HR et al. Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol. Cell Proteomics5(10), 1876–1886 (2006).
   PubMed Web of Science ®Google Scholar
• Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods4(10), 828–823 (2007).
   PubMed Web of Science ®Google Scholar
• Shimma S, Sugiura Y, Hayasaka T, Zaima N, Matsumoto M, Setou M. Mass imaging and identification of biomolecules with MALDI-QIT-TOF-based system. Anal. Chem.80(3), 878–885 (2008).
   PubMed Web of Science ®Google Scholar
• Taban IM, Altelaar AFM, van der Burgt YEM et al. Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry. J. Am. Soc. Mass Spectrom.18(1), 145–151 (2007).
   PubMed Web of Science ®Google Scholar
• Hsieh Y, Casale R, Fukuda E et al. Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun. Mass Spectrom.20(6), 965–972 (2006).
   PubMed Web of Science ®Google Scholar
• Goodwin RJA, Penington SR, Pitt AR. Protein and peptides in pictures: imaging with MALDI mass spectrometry. Proteomics8(18), 3785–3800 (2008).
   PubMed Web of Science ®Google Scholar
• Chaurand P, Norris JL, Cornett DS, Mobley JA, Caprioli RM. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J. Proteome Res.5(11), 2889–2900 (2006).
   PubMed Web of Science ®Google Scholar
• Yao I, Sugiura Y, Matsumoto M, Setou M. In situ proteomics with imaging mass spectrometry and principal component analysis in the Scrapper-knockout mouse brain. Proteomics8(18), 3692–3701 (2008).
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Weil RJ, Thompson RC et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res.65(17), 7674–7681 (2005).
   PubMed Web of Science ®Google Scholar
• Lemaire R, Menguellet SA, Stauber J et al. Specific MALDI imaging and profiling for biomarler hunting and validation: fragment of the 11S proteasome activator complex, Reg α fragment, is a new potential ovary cancer biomarker. J. Proteome Res.6(11), 4127–4134 (2007).
   PubMed Web of Science ®Google Scholar
• Walch A, Rauser S, Deninger SO, Höfler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem. Cell Biol.130(3), 421–434 (2008).
   PubMed Web of Science ®Google Scholar
• Deninger SO, Ebert MP, Fütterer A, Gerhard M, Röcken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J. Proteome Res.7(12), 5230–5236 (2008).
   Google Scholar
• McCombie G, Staab D, Stoeckli M, Knochenmuss R. Spatial and spectral correlations in MALDI mass spectrometry images by clustering and multivariate analysis. Anal. Chem.77(19), 6118–6124 (2005).
   PubMed Web of Science ®Google Scholar
• Groseclose MR, Andersson M, Hardesty WM et al. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J. Mass Spectrom.42(2), 254–262 (2007).
   PubMed Web of Science ®Google Scholar
• Stauber J, Lemaire R, Franck J et al. MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting. J. Proteome Res.7(3), 969–978 (2008).
   PubMed Web of Science ®Google Scholar
• Chen Y, Choong LY, Lin Q et al. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell Proteomics6(12), 2072–2087 (2007).
   PubMed Web of Science ®Google Scholar
• Huang PY, Cavenee WK, Furnari FB, White FM. Uncovering therapeutic targets for glioblastoma: a systems biology approach. Cell Cycle6(22), 2750–2754 (2007).
   PubMed Web of Science ®Google Scholar
• Guha U, Chaerkady R, Marimuthu A et al. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc. Natl Acad. Sci. USA105(37), 14112–14117 (2008).
   PubMed Web of Science ®Google Scholar
• Rikova K, Guo A, Zeng Q et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell131(6), 1190–1203 (2007).
   PubMed Web of Science ®Google Scholar
• Singh AP, Senapati S, Ponnusamy MP et al. Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol.9(11), 1076–1085 (2008).
   PubMed Web of Science ®Google Scholar
• Syka JEP, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA101(26), 9528–9533 (2004).
   PubMed Web of Science ®Google Scholar
• Wiesner J, Premsler T, Sickmann A. Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications. Proteomics8(21), 4466–4483 (2008).
   PubMed Web of Science ®Google Scholar
• Hayakawa S, Hashimoto M, Matsubara H, Turecek F. Dissecting the proline effect: dissociations of proline radicals formed by electron transfer to protonated Pro-Gly and Gly-Pro dipeptides in the gas phase. J. Am. Chem. Soc.129(25), 7936–7949 (2007).
   PubMedGoogle Scholar
• Good DM, Wirtala M, McAlister GC, Coon JJ. Performance characteristics of electron transfer dissociation mass spectrometry. Mol. Cell Proteomics6(11), 1942–1951 (2007).
   PubMed Web of Science ®Google Scholar
• Han H, Xia Y, Yang M, McLuckey SA. Rapidly alternating transmission mode electron-transfer dissociation and collisional activation for the characterization of polypeptide ions. Anal. Chem.80(9), 3492–3497 (2008).
   Google Scholar
• Han H, Xia Y, McLuckey SA. Ion trap collisional activation of c and z• ions formed via gas-phase ion/ion electron-transfer dissociation. J. Proteome Res.6(8), 3062–3069 (2007).
   Google Scholar
• Chi A, Huttenhower C, Geer LY et al. Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry. Proc. Natl Acad. Sci. USA104(7), 2193–2198 (2007).
   PubMed Web of Science ®Google Scholar
• Molina H, Matthiesen R, Kandasamy K, Pandey A. Comprehensive comparison of collision induced dissociation and electron transfer dissociation. Anal. Chem.80(13), 4825–4835 (2008).
   Google Scholar
• Catalina MI, Koeleman CAM, Deelder AM, Wuhrer M. Electron transfer dissociation of N-glycopeptides: loss of the entire N-glycosylated asparagine side chain. Rapid Commun. Mass Spectrom.21(6), 1053–1061 (2007).
   Google Scholar
• Abbott KL, Aoki K, Lim JM et al. Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res.7(4), 1470–1480 (2008).
   PubMed Web of Science ®Google Scholar
• Yan A, Lennarz WJ. Unraveling the mechanism of protein N-glycosylation. J. Biol. Chem.280(5), 3121–3124 (2005).
   PubMed Web of Science ®Google Scholar
• Danielle H, Bertozzi CR. Glycans in cancer and inflammation – potential for therapeutics and diagnostics. Nat. Rev. Drug Discov.4(6), 477–488 (2005).
   Google Scholar
• Morelle W, Canis K, Chirat F, Faid V, Michalski J-C. The use of mass spectrometry for the proteomic analysis of glycosylation. Proteomics6(14), 3993–4015 (2006).
   PubMed Web of Science ®Google Scholar
• Hogan JM, Pitteri SJ, Chrisman PA, McLuckey SA. Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision induced dissociation. J. Proteome Res.4(2), 628–632 (2005).
   Google Scholar
• Mikesh LM, Ueberheide B, Chi A et al. The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta1764(12), 1811–1822 (2006).
   PubMed Web of Science ®Google Scholar
• States DJ, Omenn GS, Blackwell TW et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol.24(3), 333–338 (2006).
   PubMed Web of Science ®Google Scholar
• Wulfkuhle JD, Edmiston KH, Liotta LA, Petricoin EF 3rd. Technology insight: pharmacoproteomics for cancer – promises of patient-tailored medicine using protein microarrays. Nat. Clin. Pract. Oncol.3(5), 256–268 (2006).
   PubMedGoogle Scholar
• Tibes R, Qiu Y, Lu Y et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther.5(10), 2512–2521 (2006).
   PubMed Web of Science ®Google Scholar
• LaBaer J, Ramachandran N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol.9(1), 14–19 (2005).
   PubMed Web of Science ®Google Scholar
• Ramalingam S, Honkanen P, Young L et al. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer Res.67(13), 6247–6252 (2007).
   Google Scholar
• Nishizuka S, Ramalingam S, Spurrier B et al. Quantitative protein network monitoring in response to DNA damage. J. Proteome Res.7(2), 803–808 (2008).
   PubMed Web of Science ®Google Scholar
• Petricoin EF 3rd, Bichsel VE, Calvert VS et al. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J. Clin. Oncol.23(15), 3614–3621 (2005).
   PubMed Web of Science ®Google Scholar
• Sheehan KM, Calvert VS, Kay EW et al. Use of reverse-phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell Proteomics4(4), 346–355 (2005).
   PubMed Web of Science ®Google Scholar
• Zha H, Raffled M, Charboneau L et al. Similarities of prosurvival signals in Bcl 2-positive and Bcl 2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest.84(2), 235–244 (2004).
   PubMed Web of Science ®Google Scholar
• Major SM, Nishizuka S, Morita D et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics7, 192 (2006).
   PubMedGoogle Scholar
• Spurrier B, Washburn FL, Asin S, Ramalingam S, Nishizuka S. Antibody screening database for protein kinetic modeling. Proteomics7(18), 3259–3263 (2007).
   Google Scholar
• Ciliberto A, Novak B, Tyson JJ. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle4(3), 488–493 (2005).
   PubMed Web of Science ®Google Scholar
• Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky GA. A plausible model for the digital response of p53 to DNA damage. Proc. Natl Acad. Sci. USA102(40), 14266–14271 (2005).
   PubMed Web of Science ®Google Scholar
• Madoz-Gurpide J, Kuick R, Wang H, Misek DE, Hanash SM. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol. Cell. Proteomics7(2), 268–281 (2007).
   PubMed Web of Science ®Google Scholar
• Canterbury JD, Yi X, Hoopmann MR, MacCoss MJ. Assessing the dynamic range and peak capacity of nanoflow LC-FAIMS-MS on an ion trap mass spectrometer for proteomics. Anal. Chem.80(18), 6888–6897 (2008).
   Google Scholar
• Coombes KR, Morris JS, Hu J, Edmonson SR, Baggerly KA. Serum proteomics – a young technology begins to mature. Nat. Biotechnol.23(3), 291–292 (2005).
   PubMed Web of Science ®Google Scholar
• Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin. Chem.51(1), 3–5 (2005).
   PubMed Web of Science ®Google Scholar
• Omenn GS, States DJ, Adamski M et al. Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics5(13), 3226–3245 (2005).
   PubMed Web of Science ®Google Scholar
• Rai AJ, Gelfrand CA, Haywood BC et al. HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics5(13), 3262–3277 (2005).
   PubMed Web of Science ®Google Scholar
• Mann M. Can proteomics retire the western blot? J. Proteome Res.7(8), 3065 (2008).
   PubMed Web of Science ®Google Scholar